Solriamfetol for Binge Eating Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a Phase 3, multi-center, open-label study to evaluate the long-term safety and efficacy of solriamfetol in the treatment of binge eating disorder (BED) in adults.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if there has been a significant change in your medications since the previous study, it might affect your eligibility.
Is solriamfetol safe for humans?
What data supports the effectiveness of the drug Solriamfetol for treating binge eating disorder?
Are You a Good Fit for This Trial?
This trial is for adults with Binge Eating Disorder (BED) who are looking to participate in a study evaluating the long-term safety and effectiveness of a medication called Solriamfetol. Specific eligibility criteria details were not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Baseline
Initial assessment and baseline measurements before treatment begins
Titration
Participants undergo a 2-week titration phase to adjust dosing of solriamfetol
Maintenance
Participants receive solriamfetol for long-term treatment of binge eating disorder
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Solriamfetol
Find a Clinic Near You
Who Is Running the Clinical Trial?
Axsome Therapeutics, Inc.
Lead Sponsor